Design of Magnetic Polymeric Particles as a Stimulus-Responsive System for Gastric Antimicrobial Therapy-Reference-Cited by-同舟云学术

Design of Magnetic Polymeric Particles as a Stimulus-Responsive System for Gastric Antimicrobial Therapy

Published:2016-12-13 Issue:6 Volume:18 Page:2026-2036
ISSN:1530-9932
Container-title:AAPS PharmSciTech
language:en
Short-container-title:AAPS PharmSciTech

Author:

Silva-Freitas Erica L.,Pontes Thales R. F.,Araújo-Neto Rafael P.,Damasceno Ítalo H. M.,Silva Kátia L.,Carvalho Juliana F.,Medeiros Aldo C.,Silva Rodolfo B.,Silva Amanda K. A.,Morales Marco A.,Egito Eryvaldo S. T.,Dantas Ana L.,Carriço Artur S.

Publisher

Springer Science and Business Media LLC

Subject

Drug Discovery,Pharmaceutical Science,Agronomy and Crop Science,Ecology,Aquatic Science,General Medicine,Ecology, Evolution, Behavior and Systematics

Link

http://link.springer.com/article/10.1208/s12249-016-0673-1/fulltext.html

Reference47 articles.

1. Amieva MR, El-Omar EM. Host-Bacterial Interactions in Helicobacter pylori infection. Gastroenterology. 2008;134(1):306–23. 385.

2. Yoshiyama H, Nakazawa T. Unique mechanism of Helicobacter pylori for colonizing the gastric mucus. Microbes Infect. 2000;2(1):55–60.

3. Gerrits MM, van Vliet AH, Kuipers EJ, Kusters JG. Helicobacter pylori and antimicrobial resistance: molecular mechanisms and clinical implications. Lancet Infect Dis. 2006;6(11):699–709.

4. Archimandritis A, Avgerinos A, Nakos A, Viazis N, Skandalis N, Tzivras M. Open- label study of a regimen consisting of 1 week of lansoprazole, clarithromycin, and amoxicillin followed by 3 weeks of lansoprazole in healing peptic ulcer and eradicating Helicobacter pylori. Curr Ther Res. 2000;61(7):406–13.

5. Genta RM, Huberman RM, Graham DY. The gastric cardia in Helicobacter pylori infection. Hum Pathol. 1994;25(9):915–9.

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Leading Paediatric Infectious Diseases—Current Trends, Gaps, and Future Prospects in Oral Pharmacotherapeutic Interventions;Pharmaceutics;2024-05-26

2. Stimulus-responsive biomaterials for Helicobacter pylori eradication;Journal of Advanced Research;2023-12

3. Treatment of H. pylori infection and gastric ulcer: Need for novel Pharmaceutical formulation;Heliyon;2023-10

4. Recent Advances in Combating Bacterial Infections by Using Hybrid Nano-Systems;Journal of Nanotheranostics;2023-09-08

5. Recent advances in mucus-penetrating nanomedicines for oral treatment of colonic diseases;Expert Opinion on Drug Delivery;2023-07-31